Morgan Stanley & Co. Int'l plc Stabilisation Notice (8290N)
03 Februar 2016 - 8:00AM
UK Regulatory
TIDM19PK TIDMTTM TIDMCYBG
RNS Number : 8290N
Morgan Stanley & Co. Int'l plc
03 February 2016
Not for distribution, directly or indirectly, in or into the
United States or any jurisdiction in which such distribution would
be unlawful.
CYBG PLC (the "Company")
Stabilisation Notice
03 February 2016
Morgan Stanley & Co. International plc (contact: Martin
Thorneycroft: telephone: +44 (0) 20 7425 8000) hereby gives notice
that the Stabilising Manager named below and its affiliates may
stabilise the offer of the following securities in accordance with
Commission Regulation (EC) No. 2273/2003 implementing the Market
Abuse Directive (2003/6/EC).
The securities:
---------------------------------------------------------------
Issuer: CYBG PLC
------------------- ------------------------------------------
Securities: Ordinary shares ("Shares") of the
Issuer (ISIN: GB00BD6GN03)
CHESS Depositary Interests ("CDIs")
if the Issuer (ISIN: AU000000CYB7)
------------------- ------------------------------------------
Offer size: 191,155,491 Shares ("Offer Shares")
(excluding the over-allotment option)
------------------- ------------------------------------------
Offer price: 185 pence per Share
------------------- ------------------------------------------
Stabilisation:
---------------------------------------------------------------
Stabilising Morgan Stanley & Co. International
Manager: plc, 25 Cabot Square, Canary Wharf,
London E14 4QA
------------------- ------------------------------------------
Stabilisation 03 February 2016 at 8:00 a.m.
period expected
to start on:
------------------- ------------------------------------------
Stabilisation 4 March 2016
period expected
to end no later
than:
------------------- ------------------------------------------
Maximum size Up to 28,673,323 Shares
of over-allotment
facility:
------------------- ------------------------------------------
Over-allotment Option:
---------------------------------------------------------------
Terms: The Issuer has granted Morgan Stanley
& Co. International plc, in its capacity
as stabilisation manager, and for
the account of the underwriters, the
option to acquire up to an additional
28,673,323 Shares at the Offer Price
(representing up to 15 per cent of
the Offer size). Any exercise of the
Over-allotment Option may be settled
by the Selling Shareholder in cash.
------------------- ------------------------------------------
Duration: This option may be executed at any
time during the stabilisation period.
------------------- ------------------------------------------
In connection with the offer of the above securities, the
Stabilising Manager may over-allot the securities or effect
transactions with a view to supporting the market price of the
securities at a level higher than that which might otherwise
prevail. However, there is no assurance that the Stabilising
Manager will take any stabilisation action and any stabilisation
action, if begun, may be ended at any time.
This announcement is for information purposes only and does not
constitute an invitation or offer to underwrite, subscribe for or
otherwise acquire or dispose of any securities of the Issuer in any
jurisdiction.
This announcement and the offer of the securities to which it
relates are only addressed to and directed at persons outside the
United Kingdom and persons in the United Kingdom who have
professional experience in matters related to investments or who
are high net worth persons within article 12(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 and
must not be acted on or relied on by other persons in the United
Kingdom.
In addition, if and to the extent that this announcement is
communicated in, or the offer of the securities to which it relates
is made in, any EEA Member State that has implemented Directive
2003/71/EC (together with any applicable implementing measures in
any Member State, the "Prospectus Directive") before the
publication of a prospectus in relation to the securities which has
been approved by the competent authority in that Member State in
accordance with the Prospectus Directive (or which has been
approved by a competent authority in another Member State and
notified to the competent authority in that Member State in
accordance with the Prospectus Directive), this announcement and
the offer are only addressed to and directed at persons in that
Member State who are qualified investors within the meaning of the
Prospectus Directive (or who are other persons to whom the offer
may lawfully be addressed) and must not be acted on or relied on by
other persons in that Member State.
This announcement is not an offer of securities for sale into
the United States. The securities have not been, and will not be,
registered under the United States Securities Act of 1933 and may
not be offered or sold in the United States absent registration or
an exemption from registration. There will be no public offer of
securities in the United States.
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
STATTMITMBBMBTF
(END) Dow Jones Newswires
February 03, 2016 02:00 ET (07:00 GMT)
Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
Von Jul 2023 bis Jul 2024